PDS Biotechnology (PDSB) announced the appointment of Kirk Shepard as CMO, effective immediately. Shepard succeeds Lauren Wood who is retiring from the Company after five years in the role. Dr. Wood will continue to be available to PDS Biotech during a handover period to facilitate the transition of the role to Dr. Shepard. Prior to joining PDS Biotech, Dr. Shepard was Chief Medical Officer, Senior Vice President and Head of the Global Medical Affairs Oncology Business Group at Eisai (ESAIY).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PDSB:
- PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer
- PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference
- PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Apyx Medical appoints Matthew Hill as CFO
- PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
